Allergan, PLC. has recalled approximately 168,768 blister cards of Taytulla (norethindrone acetate and ethinyl estradiol) softgel capsules distributed as physician samples. The recall was issued because the capsules in some packs are arranged out of sequence, meaning the first four days of the treatment pack may contain inactive placebo pills instead of active medication. This packaging defect can cause the medication to fail, which could lead to an unintended pregnancy. These affected samples were distributed to healthcare providers nationwide.
Taking the pills in the wrong order significantly reduces the effectiveness of the birth control. If a consumer takes the inactive maroon pills during the first four days of their cycle instead of the active pink pills, there is a high risk of ovulation and unintended pregnancy.
You have 2 options:
Return for refund or replacement
Medical Consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.